Were 1/3 of Pfizer Shots in the EU "Placebos"?

German chemistry professors reveal gravely suspicious conduct at the Paul Ehrlich Institute (responsible for quality control of Pfizer-BioNTech shots).

By JOHN LEAKE

From the beginning of the COVID-19 vaccine fiasco, I always sensed that all of the elements were in place for program to be a massive fraud. The program—hastily rolled out under the pressure of a purported emergency, with no proper testing, and with governments such as the European Union pre-purchasing the product for entire populations—promised overnight, windfall profits for the companies involved. Surely, I thought, this created an enormous temptation for Pfizer (which has a long civil and criminal rap sheet) and its venal friends in place like Washington and Brussels to perpetrate a gigantic fraud.

Dr. McCullough and I often talked about the COVID-19 vaccine program as an experiment on the entire population, and that those of us who refused the shot were apparently the control group. The relentless pressure and coercion applied to us in 2021 raised the suspicion that the Bio-Pharmaceutical Complex was desperate to eliminate the control group so that the true results of its massive experiment would never be ascertained.

A few months ago, Dr. McCullough was astonished by the results of a Danish study that revealed massive variations of side effects associated with different batches of the Pfizer-BioNTech vaccine administered in Denmark. He wrote about the Danish study on our Substack and discussed it with Senator Ron Johnson, who has long been concerned about manufacturing variations and defects in COVID-19 vaccine batches.

The Danish study revealed that just 4.2% of the vaccine batches were associated with the majority of severe adverse events. Conversely <1% of these events were associated with 32.1% of the batches. Over dinner one night this spring, he expressed his astonishment that a full third of the vaccines seemed to be associated with almost ZERO side effects, while just 4.2% of the batches were associated with an extremely high number of adverse events. What could account for this stunning variation?

Dr. McCullough was not the only scientist who wondered about this. In Germany, Dr. Gerald Dyker, Professor of Organic Chemistry at the Ruhr-Uni Bochum and Dr. Jörg Matysik, Professor of Analytical Chemistry at the University of Leipzig, were also stunned by the results of the Danish study.

Since the experimental Pfizer-BioNTech COVID-19 Vaccine was authorized in the EU in December of 2020, both professors have been concerned about what they perceived to be a lack of proper testing and manufacturing quality control. And so, following the publication of the Danish study, they set about investigating the cause of this huge variation. A natural starting place was the Paul Ehrlich Institute—the German federal agency, medical regulatory body and research institution for vaccines and biomedicines.

Because the Pfizer-BioNTech COVID-19 Vaccine is manufactured by the German company BioNTech—and because Germany is a founding member of the European Union—the Paul Ehrlich Institute is responsible for all quality-control testing of the Pfizer-BioNTech COVID-19 Vaccine distributed throughout the European Union.

As a true crime investigator, I find this arrangement to be inherently and extremely vulnerable to the temptation to commit fraud. That is to say, if the lords at Pfizer-BioNTech wanted to corrupt the process of quality-control testing of their experimental product, all they would have to do is corrupt the guys at the top of one institution.

As Professors Dyker and Matysik presented in a conversation with a German podcaster on June 22, 2023, the Paul Ehrlich Institute was indeed responsible for the quality-control testing of the three vaccine lots that were the subject of the Danish study.

What is astonishing (and almost certainly evidence of fraud) is that the Institute somehow knew in advance that it wasn’t necessary to perform quality-control tests on the 32.1% of the batches that were associated with almost zero side effects. This finding is illustrated with the following graphs:

The first (top) graph is from the Danish study. The top (blue) line plots the high number of adverse events associated with just 4.2% of the batches. The middle (green line) plots the moderate number of adverse events associated with 63.7% of the batches. The lowest (yellow) line expresses the virtually zero number of side effects associated with 32.1% of the batches.

The second (lower) graph was compiled by Professors Dyker and Matysik and is titled “Which Batches from the Danish Study did the Paul Ehrlich Institute Test?”

The left (blue) batches are those associated with the extremely high rate of adverse events. The Paul Ehrlich Institute tested ALL of these batches and apparently found nothing defective about them.

The middle (green) column displays the batches that were associate with a moderate number of adverse events in the Danish study. The Paul Ehrlich Institute tested all but two these batches and found nothing defective about them.

The right (yellow) column displays the batches that were associated with virtually zero adverse events. The Paul Ehrlich Institute only deemed it necessary to test ONE of these batches. WHY?